Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK)
CUSIP: 74933X609
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per shar
- Shares outstanding
- 22,457,615
- Total 13F shares
- 496,945
- Share change
- -91,103
- Total reported value
- $120,200
- Price per share
- $0.24
- Number of holders
- 12
- Value change
- -$72,444
- Number of buys
- 9
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 74933X609?
CUSIP 74933X609 identifies VTAK - Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74933X609:
Top shareholders of VTAK - Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
5%
|
1,120,635
|
$257,746 | +$27,551 | 30 Jun 2025 | |
| Jenkins Casey A. |
13D/G
|
— |
9.9%
|
832,243
|
$233,028 | $0 | 31 Dec 2024 | |
| Jenkins Family Charitable Institute |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
265,226
|
$106,143 | — | 30 Aug 2024 | |
| Warberg Asset Management LLC |
13F
|
Company |
0.8%
|
180,100
|
$61,954 | — | 31 Mar 2025 | |
| David A. Jenkins |
13D/G
|
JENKINS DAVID A |
2.1%
|
194,182
|
$54,371 | $0 | 29 Jan 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
54,213
|
$18,649 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.2%
|
44,705
|
$15,379 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
32,967
|
$11,341 | — | 31 Mar 2025 | |
| William R. Enquist |
3/4/5
|
Director |
—
class O/S missing
|
24,029
|
$9,616 | — | 04 Jun 2021 | |
| Richard Mejia Jr. |
3/4/5
|
Director |
—
class O/S missing
|
21,946
|
$8,783 | — | 04 Jun 2021 | |
| Andrew C. Jackson |
3/4/5
|
CFO |
—
class O/S missing
|
21,680
|
$8,676 | — | 20 May 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.08%
|
17,721
|
$6,096 | — | 31 Mar 2025 | |
| Joan Stafslien |
3/4/5
|
Director |
—
class O/S missing
|
13,410
|
$5,367 | — | 04 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
6,157
|
$2,118 | — | 31 Mar 2025 | |
| Susanne Meline |
3/4/5
|
Director |
—
mixed-class rows
|
3,422
mixed-class rows
|
$1,365 | — | 09 Jan 2023 | |
| John P. Francis |
3/4/5
|
Director |
—
mixed-class rows
|
27,611
mixed-class rows
|
$1,045 | — | 08 Jan 2024 | |
| Jonathan Will McGuire |
3/4/5
|
CEO & Secretary, Director |
—
class O/S missing
|
1,083
|
$433 | — | 20 Nov 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,000
|
$344 | — | 31 Mar 2025 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
152
|
$52 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
68
|
$23 | — | 31 Mar 2025 | |
| Marie-Claude Jacques |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
375,000
mixed-class rows
|
— | — | 29 Jan 2025 | |
| Margrit Thomassen |
3/4/5
|
Interim CFO and Secretary |
—
class O/S missing
|
25,000
|
— | — | 08 Jan 2024 |
Institutional Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) as of Q2 2025
As of 30 Jun 2025,
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
496,945 shares.
The largest 10 holders included
HRT FINANCIAL LP, CITADEL ADVISORS LLC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, Ground Swell Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., and RAYMOND JAMES FINANCIAL INC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
10
Q2 2025 holders
12
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.